We are live on
!
Find out more
B
Bayban Portfolio holdings
AUM
$130M
This Fund
S&P 500
This Quarter
Est. Return
+19.01%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$15.3M
(+13%)
Cap. Flow
-$835K
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
42.19%
Holding
678
New
7
Increased
30
Reduced
74
Closed
83
Avg Time Held
1.9
quarters
Top 10 Avg Time Held
1.7
quarters
Top 20 Avg Time Held
1.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434K |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$339K |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$308K |
| 4 |
Tesla
TSLA
|
+$91.9K |
| 5 |
Caterpillar
CAT
|
+$87.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$475K |
| 2 |
Nuveen Dynamic Municipal Opportunities Fund
NDMO
|
+$154K |
| 3 |
Becton Dickinson
BDX
|
+$149K |
| 4 |
Procter & Gamble
PG
|
+$146K |
| 5 |
Mairs & Power Minnesota Municipal Bond ETF
MINN
|
+$125K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.34% |
| 2 | Healthcare | 16.31% |
| 3 | Technology | 12.02% |
| 4 | Financials | 9.19% |
| 5 | Consumer Staples | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SFD
551
Smithfield Foods
SFD
$7.43B
| $1.46K | ﹤0.01% |
60
| – | – |
2026 Q1
1 quarter
|
|
|
GPGI
552
GPGI Inc
GPGI
$3.74B
| $1.36K | ﹤0.01% |
86
| – | – |
2026 Q1
1 quarter
|
|
553
GE HealthCare
GEHC
$29B
| $1.34K | ﹤0.01% |
21
-62
| -75% | -$4.08K |
2025 Q4
2 quarters
|
|
554
Bath & Body Works
BBWI
$3.24B
| $1.34K | ﹤0.01% |
58
| – | – |
2026 Q1
1 quarter
|
|
555
HNI Corp
HNI
$3.38B
| $1.33K | ﹤0.01% |
33
| – | – |
2026 Q1
1 quarter
|
|
556
Perella Weinberg Partners
PWP
$1.22B
| $1.26K | ﹤0.01% |
79
| – | – |
2026 Q1
1 quarter
|
|
557
Freeport-McMoran
FCX
$103B
| $1.26K | ﹤0.01% |
20
| – | – |
2025 Q4
2 quarters
|
|
558
Raymond James Financial
RJF
$30.4B
| $1.22K | ﹤0.01% |
8
| – | – |
2026 Q1
1 quarter
|
|
559
DexCom
DXCM
$32.2B
| $1.15K | ﹤0.01% |
17
| – | – |
2025 Q4
2 quarters
|
|
560
Encompass Health
EHC
$11.8B
| $1.11K | ﹤0.01% |
11
| – | – |
2026 Q1
1 quarter
|
|
561
Diamondrock Hospitality Co
DRH
$2.57B
| $1.06K | ﹤0.01% |
87
| – | – |
2026 Q1
1 quarter
|
|
562
Organon & Co
OGN
$3.6B
| $1.04K | ﹤0.01% |
77
+20
| +35% | +$239 |
2025 Q4
2 quarters
|
|
563
Jackson Financial
JXN
$8.91B
| $1.02K | ﹤0.01% |
10
| – | – |
2026 Q1
1 quarter
|
|
564
Jacobs Solutions
J
$16.2B
| $1.01K | ﹤0.01% |
8
| – | – |
2026 Q1
1 quarter
|
|
565
Capital One
COF
$119B
| $1K | ﹤0.01% |
5
| – | – |
2025 Q4
2 quarters
|
|
566
Pentair
PNR
$8.46B
| $997 | ﹤0.01% |
13
| – | – |
2026 Q1
1 quarter
|
|
567
Banco Santander
SAN
$194B
| $856 | ﹤0.01% |
62
| – | – |
2025 Q4
2 quarters
|
|
568
Trade Desk
TTD
$5.65B
| $850 | ﹤0.01% |
47
-41
| -47% | -$871 |
2025 Q4
2 quarters
|
|
569
State Street
STT
$48.3B
| $848 | ﹤0.01% |
5
| – | – |
2025 Q4
2 quarters
|
|
570
Barclays
BCS
$79.1B
| $833 | ﹤0.01% |
31
| – | – |
2025 Q4
2 quarters
|
|
571
RGC Resources
RGCO
$227M
| $813 | ﹤0.01% |
34
| – | – |
2026 Q1
1 quarter
|
|
572
Federal Agricultural Mortgage
AGM
$2.33B
| $797 | ﹤0.01% |
4
| – | – |
2026 Q1
1 quarter
|
|
573
Sanofi
SNY
$95.7B
| $768 | ﹤0.01% |
18
| – | – |
2025 Q4
2 quarters
|
|
574
Ferrari
RACE
$68.1B
| $745 | ﹤0.01% |
2
| – | – |
2025 Q4
2 quarters
|
|
|
PSTL
575
Postal Realty Trust
PSTL
$686M
| $739 | ﹤0.01% |
30
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
4A
BNA
SCC
HGP
WHC
RHDIC
LIP
PAWC
Bayban's Q2 2026 Portfolio in Review
As of Q2 2026, Bayban held 678 positions worth $130M, up 13% from $115M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Bayban's Q2 2026 filing shows 7 new, 30 increased, 74 reduced and 83 closed positions. Its largest new stake was iShares Russell 2000 ETF: 225 shares worth $67.6K. The largest sale was UnitedHealth, an estimated $475K.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Technology.
- Bayban's largest Q2 2026 buy was iShares Russell 2000 ETF: 225 shares worth $67.6K.
- Bayban added most to Apple in Q2 2026, an estimated $434K increase.
- Bayban's biggest Q2 2026 reduction was UnitedHealth, cutting an estimated $475K.
- Bayban fully exited Nuveen Dynamic Municipal Opportunities Fund in Q2 2026, selling an estimated $154K.
- Bayban's ten largest holdings make up 42% of its $130M portfolio in Q2 2026.
- Bayban opened 7 new positions and closed 83 in Q2 2026.
- Bayban's portfolio value rose 13% quarter-over-quarter to $130M.
Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.